China Shineway Pharmaceutical Group Limited (HKG:2877)
Hong Kong · Delayed Price · Currency is HKD 9.71
-0.06 (-0.61%)
Feb 13, 2026, 4:08 PM HKT
HKG:2877 Revenue
China Shineway Pharmaceutical Group had revenue of 1.65B CNY in the half year ending June 30, 2025, a decrease of -31.10%. This brings the company's revenue in the last twelve months to 3.34B, down -20.47% year-over-year. In the year 2024, China Shineway Pharmaceutical Group had annual revenue of 3.78B, down -16.35%.
Revenue (ttm)
3.34B CNY
Revenue Growth
-20.47%
P/S Ratio
2.00
Revenue / Employee
1.17M CNY
Employees
2,867
Market Cap
7.33B HKD
Revenue Chart
* This company reports financials in CNY.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 3.78B | -738.50M | -16.35% |
| Dec 31, 2023 | 4.52B | 565.90M | 14.32% |
| Dec 31, 2022 | 3.95B | 727.09M | 22.56% |
| Dec 31, 2021 | 3.22B | 567.85M | 21.38% |
| Dec 31, 2020 | 2.66B | -50.30M | -1.86% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| China Traditional Chinese Medicine Holdings Co. | 17.08B |
| Shandong Xinhua Pharmaceutical Company | 9.28B |
| Luye Pharma Group | 6.76B |
| SSY Group | 4.58B |
| Consun Pharmaceutical Group | 3.58B |
| Sihuan Pharmaceutical Holdings Group | 2.30B |
| Beijing Tong Ren Tang Chinese Medicine Company | 1.71B |
| CanSino Biologics | 1.06B |